Controllo delle infezioni ospedaliere attraverso un sistema di sanificazione a base di probiotici: valutazione clinica ed economica

Journal title MECOSAN
Author/s Carla Rognoni, Silvio Brusaferro, Elisabetta Caselli, Luca Arnoldo, Gabriele Pelissero, Vincenza La Fauci, Paola Antonioli, Filippo Berloco, Silvano Nola, Nelso Trua, Lorenzo Tognon, Giovanni Villone, Maddalena Coccagna, Maria D’Accolti, Matteo Bisi, Luca Lanzoni, Irene Soffritti, Antonella Volta, Sante Mazzacane, Rosanna Tarricone
Publishing Year 2019 Issue 2018/107 Language Italian
Pages 18 P. 81-98 File size 407 KB
DOI 10.3280/MESA2018-107005
DOI is like a bar code for intellectual property: to have more infomation click here

Below, you can see the article first page

If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits

Article preview

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

Healthcare Associated Infections (HAI) are a global concern, influenced by the increasing drug resistance of HAI-associated pathogens. The persistent contamination of hospital surfaces contributes to HAI transmission, which is not efficiently controlled by conventional cleaning. Conventional cleaning with chemical agents does not prevent recontamination, has a high environmental impact and can favor selection of drug-resistant microbial strains. An eco-sustainable probiotic-based cleaning system (Probiotic Cleaning Hygiene System, PCHS) recently showed to stably abate surface pathogens, without selecting antibiotic-resistant species. Based on those results, a multicentre, pre-post-interventional study was performed for 18 months in the Internal Medicine wards of five Italian public hospitals, aimed to analyze the impact of PCHS on HAI incidence and related effects, such as HAI-associated antimicrobial drug consumption and costs. Surface bioburden was also analyzed. Globally, 11842 patients and 24875 environmental samples were surveyed. PCHS was associated with a significant decrease of HAI cumulative incidence from a global 4.8% to 2.3% (OR = 0.44, 95% IC 0.35 ± 0.54) (p < 0.0001). Concurrently, PCHS was associated with a stable decrease of surface pathogens, compared to conventional sanitation (mean decrease 83%, range 70 ± 96.3%). Drug consumption associated with HAI onset showed a global 60.3% decrease, with a 75.4% decrease of the associated costs. Our study provides findings which support the impact of a sanitation procedure on HAI incidence, showing that the use of a probiotic-based environmental intervention can be associated with a significant decrease of the risk to contract a HAI during hospitalization and related costs. Once confirmed in larger experiences and other target populations, this eco-sustainable approach might be considered as a part of infection control and prevention strategies.

Keywords: Healthcare associated infections, antimicrobial resistance, antibiotic consumption, antibiotic costs

  1. Allegranzi B., Bagheri Nejad S., Combescure C., Graafmans W., Attar H., Donaldson L. et al. (2011). Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet, 377(9761): 228-41.
  2. Almatroudi A., Gosbell I.B., Hu H., Jensen S.O., Espedido B.A., Tahir S. et al. (2016). Staphylococcus aureus drysurface biofilms are not killed by sodium hypochlorite: implications for infection control. J Hosp Infect., 93(3): 263-70.
  3. Bock L.J., Wand M.E., Sutton J.M. (2016). Varying activity of chlorhexidine-based disinfectants against Klebsiella pneumoniae clinical isolates and adapted strains. J Hosp Infect., 93(1): 42-8.
  4. Boyce J.M. (2007). Environmental contamination makes an important contribution to hospital infection. J Hosp Infect., 65(Suppl 2): 50-4.
  5. Caini S., Hajdu A., Kurcz A., Borocz K. (2013). Hospital-acquired infections due to multidrug-resistant organisms in Hungary, 2005-2010. Euro Surveill., 18(2).
  6. Capozzi C., Capozzi A., Visconti G., Ignisti F., Panà A., Mastrobuono I. (2004). Le infezioni ospedaliere: elementi di epidemiologia e prevenzione. Organizzazione Sanitaria, 3(4): 3-26.
  7. Carling P.C., Parry M.F., Bruno-Murtha L.A., Dick B. (2010). Improving environmental hygiene in 27 intensive care units to decrease multidrug-resistant bacterial transmission. Crit Care Med., 38(4): 1054-9.
  8. Caselli E., D’Accolti M., Vandini A., Lanzoni L., Camerada M.T., Coccagna M. et al. (2016a).
  9. Impact of a probiotic based cleaning intervention on the microbiota ecosystem of the hospital surfaces: focus on the resistome remodulation. PLoS One, 11(2): e0148857.
  10. Caselli E., Antonioli P., Mazzacane S. (2016b). Safety of probiotics used for hospital environmental sanitation. J Hosp Infect., 94(2): 193-4.
  11. Caselli E., Mazzacane S. (2016c). Influence of sanitizing methods on healthcare associated infections: comparison between traditional and innovative probiotic-based approaches. ISRCTN Registry. DOI: 10.1186/ISRCTN58986947
  12. Caselli E., D’Accolti M., Soffritti I., Zatelli M.C., Rossi R., Degli Uberti E. et al. (2017). HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis. Virol J., 14(1): 3.
  13. Cornejo-Juarez P., Vilar-Compte D., Perez-Jimenez C., Namendys-Silva S.A., Sandoval-Hernandez S., Volkow-Fernandez P. (2015). The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit. Int J Infect Dis., 31: 31-4.
  14. Dancer S.J. (2009). The role of environmental cleaning in the control of hospital-acquired infection. J Hosp Infect., 73(4): 378-85.
  15. Dancer S.J. (2014). Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination. Clin Microbiol Rev., 27(4): 665-90.
  16. Donskey C.J. (2013). Does improving surface cleaning and disinfection reduce health care-associated infections?. Am J Infect Control., 41(5 Suppl): S12-9.
  17. ECDC. European surveillance of healthcare associated infections in intensive care units: HAI-Net ICU protocol, version 1.02.2015 Mar 18. In: European Centre for Disease Prevention and Control, Publication & data [-- www.ecdc.europa.eu].
  18. Elias C., Moja L., Mertz D., Loeb M., Forte G., Magrini N. (2017). Guideline recommendations and antimicrobial resistance: the need for a change. BMJ Open., Jul 26,7(7): e016264.
  19. Elshaghabee F.M.F., Rokana N., Gulhane R.D., Sharma C., Panwar H. (2017). Bacillus as potential probiotics: status, concerns, and future perspectives. Front Microbiol., 8: 1490.
  20. Goodman E.R., Platt R., Bass R., Onderdonk A.B., Yokoe D.S., Huang S.S. (2008). Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol., 29(7): 593-9.
  21. Hall L., Farrington A., Mitchell B.G., Barnett A.G., Halton K., Allen M. et al. (2016). Researching effective approaches to cleaning in hospitals: protocol of the REACH study, a multi-site steppedwedge randomized trial. Implement Sci., 11: 44.
  22. Hota B. (2004). Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection?. Clin Infect Dis., 39(8): 1182-9.
  23. Ilinskaya O.N., Ulyanova V.V., Yarullina D.R., Gataullin I.G. (2017). Secretome of intestinal Bacilli: a natural guard against pathologies. Front Microbiol., 8: 1666.
  24. Kramer A., Schwebke I., Kampf G. (2006). How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis., 6: 130.
  25. La Fauci V., Costa G.B., Anastasi F., Facciolà A., Go C., Squeri R. (2015). An innovative approach to
  26. hospital sanitization using probiotics: in vitro and field trials. Microbial & Biochemical Technology., 7(3): 5.
  27. Mancini A., Verdini D., La Vigna G., Recanatini C., Lombardi F.E., Barocci S. (2016). Retrospective analysis of nosocomial infections in an Italian tertiary care hospital. New Microbiol., 39(3).
  28. McFarland L.V. (2014). Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open., 4(8): e005047.
  29. Messineo A., Marsella L.T. (2015). Biological hazards and healthcare-associated infections in Italian healthcare facilities: some considerations on inspections and accountability. Ann Ig., 27(6): 799-807.
  30. Mitchell B.G., Dancer S.J., Anderson M., Dehn E. (2015). Risk of organism acquisition from prior room occupants: a systematic review and meta-analysis. J Hosp Infect., 91(3): 211-7.
  31. Otter J.A., Yezli S., French G.L. (2011). The role played by contaminated surfaces in the transmission of nosocomial pathogens. Infect Control Hosp Epidemiol., 32(7): 687-99.
  32. Rosenbaum P.R., Rubin D.B. (1983). The Central Role of the Propensity Score in Observational Studies for Causal Effects. Biometrika, Apr., 70(1): 15.
  33. Rutala W.A., Weber D.J. (2014). Selection of the ideal disinfectant. Infect Control Hosp Epidemiol., 35(7): 855-65.
  34. Suetens C., Hopkins S., Kolman J., Diaz Hoègberg L. (2013). Point prevalence survey of healthcare associated infections and antimicrobial use in European acute care hospitals. Stockholm, Sweden. European Centre for Disease Prevention and Control. Jul 1. In: ECDC Surveillance Report [-- www.ecdc.europa.eu].
  35. Vandini A., Temmerman R., Frabetti A., Caselli E., Antonioli P., Balboni P.G. et al. (2014). Hard surface biocontrol in hospitals using microbial-based cleaning products. PLoS One., 9(9): e108598.
  36. Wand M.E., Bock L.J., Bonney L.C., Sutton J.M. (2017). Mechanisms of increased resistance to chlorhexidine and cross-resistance to colistin following exposure of Klebsiella pneumoniae clinical isolates to chlorhexidine. Antimicrob Agents Chemother., 61(1).
  37. Weber D.J., Anderson D., Rutala W.A. (2013). The role of the surface environment in healthcareassociated infections. Curr Opin Infect Dis., 26(4):
  38. 338-44. Weber D.J., Rutala W.A. (1997). Role of environmental contamination in the transmission of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol., 18(5): 306-9.
  39. Weber D.J., Rutala W.A., Miller M.B., Huslage K., Sickbert-Bennett E. (2010). Role of hospital surfaces in the transmission of emerging health care associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control..38(5 Suppl 1): S25-33.
  40. Wu L., Wu H.J., Qiao J., Gao X., Borriss R. (2015). Novel routes for improving biocontrol activity of Bacillus based bioinoculants. Front Microbiol., 6: 1395.

Carla Rognoni, Silvio Brusaferro, Elisabetta Caselli, Luca Arnoldo, Gabriele Pelissero, Vincenza La Fauci, Paola Antonioli, Filippo Berloco, Silvano Nola, Nelso Trua, Lorenzo Tognon, Giovanni Villone, Maddalena Coccagna, Maria D’Accolti, Matteo Bisi, Luca Lanzoni, Irene Soffritti, Antonella Volta, Sante Mazzacane, Rosanna Tarricone, Controllo delle infezioni ospedaliere attraverso un sistema di sanificazione a base di probiotici: valutazione clinica ed economica in "MECOSAN" 107/2018, pp 81-98, DOI: 10.3280/MESA2018-107005